2024-01-01 2024-12-31 false Capium Accounts Production 1.1 10516323 2024-01-01 2024-12-31 10516323 bus:AbridgedAccounts 2024-01-01 2024-12-31 10516323 bus:FRS102 2024-01-01 2024-12-31 10516323 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 10516323 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 10516323 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10516323 2024-01-01 2024-12-31 10516323 2024-12-31 10516323 bus:RegisteredOffice 2024-01-01 2024-12-31 10516323 core:WithinOneYear 2024-12-31 10516323 core:AfterOneYear 2024-12-31 10516323 1 2024-01-01 2024-12-31 10516323 bus:Director1 2024-01-01 2024-12-31 10516323 bus:Director1 2024-12-31 10516323 bus:Director1 2023-01-01 2023-12-31 10516323 2023-01-01 10516323 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 10516323 2023-01-01 2023-12-31 10516323 2023-12-31 10516323 core:WithinOneYear 2023-12-31 10516323 core:AfterOneYear 2023-12-31 10516323 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 10516323 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 10516323 bus:OrdinaryShareClass1 2024-12-31 10516323 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 10516323 bus:OrdinaryShareClass1 2023-12-31 10516323 core:MotorCars 2024-01-01 2024-12-31 10516323 core:MotorCars 2024-12-31 10516323 core:MotorCars 2023-12-31 10516323 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 10516323 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 10516323 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 10516323 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 10516323 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 10516323 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 10516323 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 10516323 core:Non-currentFinancialInstruments 2024-12-31 10516323 core:Non-currentFinancialInstruments 2023-12-31 10516323 core:ShareCapital 2024-12-31 10516323 core:ShareCapital 2023-12-31 10516323 core:RetainedEarningsAccumulatedLosses 2024-12-31 10516323 core:RetainedEarningsAccumulatedLosses 2023-12-31 10516323 dpl:Item1 2024-01-01 10516323 dpl:Item1 2024-12-31 10516323 dpl:Item1 2023-01-01 10516323 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10516323
England and Wales

 

 

 

A A KRISH MEDICS LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 60,599    74,814 
60,599    74,814 
Current assets      
Debtors 50,000   
Cash at bank and in hand 100,429    42,706 
150,429    42,706 
Creditors: amount falling due within one year (46,444)   (48,022)
Net current assets 103,985    (5,316)
 
Total assets less current liabilities 164,584    69,498 
Creditors: amount falling due after more than one year (90,932)  
Net assets 73,652    69,498 
 

Capital and reserves
     
Called up share capital 4 2    2 
Profit and loss account 73,650    69,496 
Shareholders' funds 73,652    69,498 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 17 September 2025 and were signed by:


-------------------------------
Amirtharajan Arumuga Venkata KRISHNAN
Director
1
General Information
A A KRISH MEDICS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10516323, registration address 7 Cassandra Close, Coventry, CV4 7HN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

2 Average number of employees

Average number of employees during the year was 2 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 01 January 2024 91,236    91,236 
Additions  
Disposals  
At 31 December 2024 91,236    91,236 
Depreciation
At 01 January 2024 16,422    16,422 
Charge for year 14,215    14,215 
On disposals  
At 31 December 2024 30,637    30,637 
Net book values
Closing balance as at 31 December 2024 60,599    60,599 
Opening balance as at 01 January 2024 74,814    74,814 


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
2 Class A shares of £1.00 each  
 

2